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Abstract
Background: Guanylate Cyclase C (GC-C) expression in the intestine plays a role in the regulation of fluid and ion
transport, as well as epithelial cell apoptosis and proliferation. In the adult rat liver, GC-C expression is increased in
response to injury. We hypothesized that GC-C is required for repair/recovery from liver injury.
Methods: We subjected wild type (WT) and GC-C deficient mice to acute liver injury with a single injection of the
hepatotoxin carbon tetrachloride. Changes in the level of expression of GC-C and its ligands uroguanylin and
guanylin were quantified by real-time PCR. Liver morphology, and hepatocyte necrosis, apoptosis and proliferation,
were examined at 1-3 days post-injury in mice on a mixed genetic background. Survival was followed for 14 days
after carbon tetrachloride injection in wild type and GC-C deficient mice on both a mixed genetic background and
on an inbred C57BL6/J background.
Results: GC-C deficient mice on the mixed genetic background nearly all died (median survival of 5 days)
following carbon tetrachloride injection while WT littermates experienced only 35% mortality. Elevated levels of
TUNEL-positive hepatocyte death on post-injury day 1, increased apoptosis on day 2, and increased areas of
centrilobular necrosis on days 2 and 3, were evident in livers from GC-C null mice compared to WT. Collectively
these data suggest increased hepatocyte death in the GC-C null mice in the early time period after injury. This
corresponds temporally with increased expression of GC-C and its ligands guanylin and uroguanylin in post-injury
WT mouse liver. The hepatocyte proliferative response to injury was the same in both genotypes. In contrast, there
was no difference in survival between GC-C null and WT mice on the inbred C57BL/6 J background in response to
acute liver injury.
Conclusions: Signalling via GC-C promotes hepatocyte survival in vivo and is required for effective recovery from
acute toxic injury to the liver in a strain-specific manner.
Background
The family of particulate guanylate cyclases (GC) is
known to play substantial roles in the function of a
number of different organs. These membrane receptors
include the natriuretic peptide receptors GC-A and GC-
B in the cardiovascular system, and GC-E and GC-F in
the retinal phototransduction system (reviewed in [1]).
GC-C is most highly expressed in the intestine where it
is the receptor for the peptides guanylin (Gn)[2] and
uroguanylin (Ugn)[3] and contributes to the mainte-
nance of fluid and salt homeostasis via ligand-activated
cGMP production. Activation of this receptor by the
bacterial heat-stable enterotoxin[4], which is very similar
in sequence and structure to the mammalian peptides
Gn and Ugn, results in secretory diarrhea in both ani-
mals and man and is a major health problem. Recent
advances in our understanding of GC-C mediated sig-
naling in intestinal epithelial cells have suggested a role
in basic cellular processes including apoptosis and pro-
liferation ([5-9].
While highest in the intestine, GC-C expression is also
found in other tissues including kidney[10], pancreas
[11], and liver. Similar to its expression in the intestine,
GC-C is temporally regulated in the liver of rodents and
is expressed at highest levels in the perinatal period
[12,13]. In the adult liver, GC-C expression is undetect-
able (by Northern analysis) but is up-regulated in
injury/regeneration models, including exposure to the
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mice with a deficiency of GC-C the liver appears normal
and no phenotype has been described under specific-
pathogen free husbandry[16,17].
Administration of CCl4 is a widely used model of
necroinflammatory liver injury and regeneration. In cen-
trilobular hepatocytes of the liver, cytochrome P450
enzymes mediate metabolism of CCl4 into toxic free
radicals which cause lipid peroxidation and membrane
damage, eventually resulting in necrosis [18]. Hepatocyte
death due to apoptosis via activation of caspase 3,
although not as prominent as death due to necrosis, has
also been demonstrated to play a role in CCl4 injury
[19-22]. Proliferation of surviving hepatocytes, along
with removal of cellular debris and restoration of the
extracellular matrix, ultimately results in liver regenera-
tion [23]. In order to explore the role of GC-C in the
liver, we compared the response of wild type (WT) and
GC-C null mice to acute CCl4 injury.
Methods
Mice
GC-C knock out (KO) mice with a targeted disruption of
the Gucy2c gene [16] were maintained on a C57BL/6J
background, following 10 backcross generations. Where
indicated, these G-CC null mice were crossed with Black
Swiss outbred mice (NTac:NIHBS, Taconic, Hudson,
NY) and the resulting heterozygous mice mated to gener-
ate homozygous wild type (WT) controls and GC-C null
littermates (F2 generation). All mice were genotyped by
PCR. Mice were housed under specific-pathogen free
conditions and fed food and water ad libitum.A d u l t
mice of both sexes, aged 8-12 weeks, were used in experi-
ments. Animal protocols were approved by the Institu-
tional Animal Care and Use Committee of the Cincinnati
Children’s Hospital Medical Center (Cincinnati, OH).
Acute Liver Injury
Mice were exposed to a single intraperitoneal injection of
CCl4 (Sigma-Aldrich, St. Louis, MO) at a dose of 1 μl
CCl4 per gram body weight as a 50% solution in corn oil.
Vehicle control mice were injected with corn oil alone.
Injections were performed within a 2 hr window to mini-
mize any variation due to circadian rhythm. Mice were
examined daily and sacrificed at the indicated times. The
liver was excised, weighed, and divided into aliquots
which were snap-frozen for later analysis, or fixed in for-
malin. After paraffin embedding, sections were either
stained with hematoxylin and eosin for light microscopic
analysis or reserved for immunohistochemistry.
Hepatocyte Death
DNA fragmentation was examined using TUNEL stain-
ing as described [5]. Briefly, tissue sections were
digested with Proteinase K, and then incubated in
freshly made reaction buffer containing terminal trans-
ferase and biotin-16-dUTP (Roche Diagnostic, Indiana-
polis, IN) to end-label DNA fragments. Labeled DNA
was detected using the Vectastain ABC-alkaline phos-
phatase system (Vector Laboratories, Burlingame, CA)
and Sigma Fast Red (Sigma-Aldrich). As a negative con-
trol, terminal transferase was omitted from the reaction
buffer. To measure hepatocyte death at 24 hours post-
CCl4 injection, the number of labeled nuclei present in
3 high-power fields per liver was counted by an investi-
gator unaware of the mouse genotype. Intense staining
of necrotic areas at later time points prevented similar
analyses. Instead, the area of necrotic damage compared
to the total area of the field, excluding blood vessels and
ducts, was determined using ImageJ version 1.38
(National Institutes of Health, Bethesda, MD), and a
percentage of necrotic damage was calculated for each
liver sample.
Apoptosis Detection
Paraffin-embedded liver sections were stained with anti-
body against activated caspase 3 (1:250 dilution, Cleaved
Caspase 3 (Asp175) Antibody, Cell Signaling Technol-
ogy, Inc., Danvers, MA) and counterstained with hema-
toxylin as described [5]. To quantify, cleaved caspase 3
-positive cells were counted in 10 randomly selected
fields per mouse liver (200× magnification) by an inves-
tigator unaware of the genotype. Caspase 3 activity was
measured using a colorimetric substrate (Ac-DEVD-
p N A ,E n z oL i f eS c i e n c e s ,P l y m o u t hM e e t i n g ,P A ) .A n
aliquot of frozen liver was homogenized in lysis buffer
containing 50 mM HEPES, pH 7.4, 5 mM CHAPS, and
5 mM DTT, and centrifuged at 20,000 × g for 30 min at
4°C. Cytosolic protein (100 μg as determined by the
Bradford assay, Bio-Rad, Hercules, CA) was incubated
overnight at 37°C with 20 mM Ac-DEVD-pNA in assay
buffer (20 mM HEPES, pH 7.4, 2 mM EDTA, 0.1%
CHAPS, and 5 mM DTT). The amount of pNA released
from the substrate was measured by determining the
absorbance value at 405 nm. The activity in control
livers from mice injected with vehicle alone did not dif-
fer between genotypes so the combined average value
was used for normalization.
Hepatocyte Proliferation
Proliferating cell nuclear antigen (PCNA) staining was
used as a marker for hepatocyte proliferation that occurs
in response to CCl4 injury. Tissue sections were deparaffi-
nized, rehydrated and endogenous peroxidase activity
quenched with 1% hydrogen peroxide for 15 min. After
washing, tissues were heated in 0.01 M sodium citrate, pH
6, to promote antigen exposure. Sections were then
washed, blocked in 3% normal goat serum, and incubated
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technology, Santa Cruz, CA) overnight at 4°C. Following
washes, sections were incubated with biotinylated anti-rab-
bit secondary antibody and labeled nuclei detected using
the Vectastain ABC-horseradish peroxidase kit and 3,3-
diaminobenzidine (Vector Laboratories). Sections were
counterstained with hematoxylin (Fisher Scientific, Pitts-
burgh, PA). As a negative control, primary antibody was
omitted. For each tissue, the hepatocyte labeling index
(percent of nuclei that stain positive for PCNA) was deter-
mined. Both PCNA-labeled and unlabeled hepatocyte
nuclei were counted in 3 high-power fields (≥ 1100 nuclei
per tissue) in a blinded fashion.
Quantitative Real-Time PCR
Total RNA was isolated from frozen liver using Tri
Reagent (Molecular Research Center, Inc., Cincinnati,
OH) according to the manufacturer’sp r o t o c o l .R N A
samples were treated with DNase I (DNA-free, Ambion,
Austin, TX) and reverse-transcribed (2 μg) using ran-
dom decamers (RETROscript, Ambion). PCR reactions
using specific gene primers were performed with Brilli-
ant II SYBR Green QPCR mix (Stratagene, La Jolla, CA)
in the Mx3000p thermocycler (Stratagene). A relative
amount for each gene examined was obtained from a
standard curve generated by plotting the cycle threshold
value against the concentration of a serially diluted RNA
sample expressing the gene of interest. This amount was
normalized to the level of 18 S RNA, which did not vary
with CCl4 treatment. Primer sequences used were as fol-
lows: GCC, forward 5’-CGAAAGCGCCTGCGTGAAGC
and reverse 5′-TTCACAGGTGCTGCTCCGGC; 18 S,
forward 5′-GATCCGAGGGCCTCACTAAAC and
reverse 5′-AGTCCCTGCCCTTTGTACACA; Ugn, for-
ward 5′-TGAGTTGGAGGAGAAGGAGATGTC and
reverse 5′-AAGGGCAAGGCTGGGTTATG; Gn, for-





Kaplan-Meier survival curves were generated for each
genotype and the log-rank test used for comparison
( P r i s m ,G r a p h P a d ,S a nD i e g o ,C A ) .T h eM a n n - W h i t n e y
test was used to evaluate the statistical significance
between 2 groups (Prism). A P value less than or equal
to 0.05 was considered significant.
Results
Decreased survival of GC-C deficient mice following liver
injury is strain-specific
Our preliminary work [25] suggested a decreased survi-
val in GC-C KO mice on a mixed genetic background
(129 and Black Swiss) compared to WT littermates in
response to a single intraperitoneal injection of CCl4.T o
recapitulate the mixed genetic background of these find-
ings we bred GC-C KO mice (> 10
th generation C57BL/
6J backcross) with outbred Black Swiss mice and utilized
homozygous WT and GC-C KO littermates (F2 genera-
tion). We first determined expression levels of GC-C
and its ligands, Gn and Ugn, in livers of WT mice.
Quantitative analysis by real-time PCR showed that GC-
C expression is relatively low in RNA from control liver
(approximately 20 times lower than in ileum, data not
shown). Two days after a single injection of CCl4 (1 μl
CCl4 per gram body weight) expression of GC-C in the
liver doubled (Figure 1A) compared to vehicle-treated
mice (P ≤ 0.03, N = 3-4 mice per time point). Ugn and
Gn expression is detectable in control liver by real-time
PCR (Figure 1B and 1C). After CCl4 administration, the
expression of both GC-C ligands also increased signifi-
cantly (P = 0.03, vehicle Day 2 vs. CCl4 Day 2, N = 4
mice per time point).
We next compared the response to CCl4 -induced
liver injury in WT and GC-C KO littermates. Cyp2e1 is
a key cytochrome P450 enzyme responsible for metabo-
lism of CCl4 into hepatotoxic radicals. Expression levels
in the liver were similar between vehicle injected WT
and GC-C KO mice and decreased markedly in both at
Day 1 (Figure 1D) as has been previously described in
the CCl4 model [24]. As shown in Figure 2, the liver-to-
body weight ratio, which is reflective of liver regenera-
tion [26,27] increased as expected after CCl4 injection in
WT mice and was significantly different from control at
both Days 3 and 5. Liver mass increased in a similar
fashion for GC-C KO mice up to Day 3 (GC-C KO
vehicle, n = 7 vs. Day 3, n = 10, * P = 0.05) but was not
significantly different at Day 5 (n = 3). By Day 5 it was
obvious that there was more lethality in GC-C KO mice
compared to WT in response to CCl4 administration.
Additional mice of both genotypes were injected and
survival was documented for 14 days. WT littermates
exhibited 65% survival through Day 14 (Figure 3A)
while nearly all GC-C null mice died by Day 9 following
injection (P = 0.001, median survival 5 days), thus indi-
cating a protective role for GC-C action throughout this
time period in mice of mixed genetic background.
We asked whether GC-C signaling was also a factor in
survival of mice on the inbred C57BL/6 background (>
10 backcross generations). As shown in Figure 1B, there
was no significant difference in survival between GC-C
null and WT mice (58% vs. 75%) on the inbred back-
ground. Therefore, the protective role of GC-C in liver
injury is strain-specific. We utilized mice of mixed
genetic background to further characterize the role of
GC-C in our subsequent studies since they demon-
strated a profound difference in survival.
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mice
In response to CCl4 exposure, centrilobular hepatocyte
necrosis and apoptosis occur during the injury process.
We therefore determined the amount of DNA breaks, as
assessed by TUNEL staining (Figure 4), in liver sections
of both genotypes at 1 Day after CCl4 injection.
TUNEL-stained nuclei were observed in GC-C KO liver
sections at 4 times the level seen in WT liver sections
(median KO 104 vs. WT 24 nuclei, P = 0.005, N = 6-7
mice per genotype). We next examined H&E stained
liver tissue sections from Days 2 and 3 following CCl4
injection. The extent of centrilobular necrosis appears to
be increased at Days 2 and 3 in the GC-C KO (repre-
sentative photomicrographs shown in Figure 5) and we
used morphometric analysis to determine the extent of
necrotic area. The percent necrotic area per liver was
estimated from measurements of 3 microscopic fields
(100×) per mouse. On both Day 2 and Day 3 (Figure 6)
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Figure 1 Expression of GC-C, Ugn and Gn is increased after acute liver injury. Quantitative real-time PCR was used to examine expression
at 1 and 2 days after CCl4 injection compared to vehicle (corn oil alone) injected mice. Expression of the receptor (A) and both ligand genes (B
and C) is increased at 2 days after CCl4 injection. (D) Cyp2e1 expression is decreased in both genotypes after CCl4 injection. Similar levels of
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Figure 2 Increase in liver mass following CCl4 treatment.F o r
both genotypes liver mass (presented as the percent of body
weight for each mouse, bar represents the median value) increased
after CCl4 injury as expected. The difference was statistically
significant at both Day 3 and Day 5 for the WT mice (vs. WT vehicle,
* P = 0.05, ** P = 0.01). Liver mass increases in a similar fashion for
GC-C KO mice up to Day 3 (GC-C KO vehicle vs. Day 3, * P = 0.05)
but is not significantly different by Day 5.
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and Day 3, 33% vs.19%, P = 0.04, N = 4-8 mice per gen-
otype. By Day 5 all WT mice (N = 3) are in recovery
and showed comparable levels of inflammatory infiltrate;
however, 1/3 surviving GC-C null mice continued to
exhibit some areas of focal necrosis (data not shown).
Both necrotic and apoptotic cell death processes can
result in TUNEL-positive staining. To look specifically
at hepatocyte death caused by apoptosis, we examined
liver sections for activated (cleaved) caspase 3 staining
by immunohistochemistry (IHC.) No staining was
detected in any of the vehicle injected control livers (not
shown). A low level of cleaved caspase 3-stained hepato-
cytes was visible in sections from WT CCl4 -injected
mice (Figure 7A). Stained cells were detectable at
equivalent levels in WT mice from Day 1 through Day 3
post-CCl4 (Figure 7B). In contrast, by Day 2 the number
of stained cells was significantly greater in GC-C KO
livers (P = 0.04), and then decreased by Day 3 to levels
comparable to WT. To confirm these findings we also
determined Caspase 3 activity in liver homogenates
using a colorimetric substrate (Figure 7C). Similar to
our IHC findings, the level of Caspase 3 activity was
greater in GC-C KO livers than WT at Day 2 (P = 0.03).
Hepatocyte proliferation is normal in GC-C null mice
We next examined the timing and extent of the wave of
hepatocyte proliferation that occurs in response to CCl4
-mediated hepatocellular death. PCNA (proliferating cell
nuclear antigen) staining is a marker for cellular prolif-
eration and is seen only in nuclei during either G1 or S
phases of the cell cycle. As shown in Figure 8, the per-
cent of hepatocyte nuclei positive for PCNA increased
in both genotypes from 1 day through 3 days post-CCl4
injury. Although there was a trend towards a reduction
in the level of PCNA-positive nuclei in the GC-C KO
mice, there was no significant difference between the 2
genotypes at any of the time points examined.
Discussion
This study demonstrates that GC-C, known primarily
for its role in intestinal epithelial cell function, also
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Figure 3 Survival of GC-C KO mice following acute CCl4 injury. Mice were injected intraperitoneally with 1 μl CCl4 per gram body weight as
a 50% solution in corn oil and checked daily for 2 weeks. (A) In the outbred Black Swiss F2 generation, 65% of WT littermates survived while
only 1 GC-C null mouse was alive at Day 14 post-injection. (P = 0.0008, N = 19 WT mice, N = 30 GC-C null mice). (B) No difference in survival is
seen between the 2 genotypes in the C57BL/6 J background. N = 12 mice per group.
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GC-C null mice do not survive the acute liver injury
mediated by a dose of CCl4 that causes 35% lethality in
WT mice. The median length of survival is 5 days with
almost all GC-C KO mice succumbing by post-injury
day 9.
There was no effect on survival in GC-C deficient
mice on the C57Bl/6J inbred background following toxic
liver injury (Figure 3). Strain-specific differences in the
phenotype of gene mutations are found in the literature,
especially in the study of multigenic diseases such as
cancer and diabetes [28]. For example, the C57BL/6J
strain is known to be resistant to liver tumorigenesis in
response to the chemical diethylnitrosamine and thus
was used to elucidate the role of p27Kip1 as a tumor
suppressor [29]. This strain is also resistant to liver
fibrosis following chronic CCl4 administration, most
probably due to a predominantly Th1 cytokine response
compared to a Th2 response in susceptible strains [30].
At this time the C57BL/6J-specific factors that are
responsible for the successful recovery of GC-C KO
mice after liver injury have not been identified. Our use
of the outbred Black Swiss mouse was crucial in unco-
vering the lack of survival following liver injury in the
GC-C KO [24] that was not seen on the C57Bl/6J
inbred background. However, the concomitant indivi-
dual variability also complicates the study of the
mechanism (s) of GC-C action. We focused our research
on comparing the early hallmarks of hepatocyte apopto-
sis/necrosis and subsequent proliferation in both












































Figure 4 Enhanced hepatocyte damage in GC-C null mice after CCl4 injection. TUNEL staining was used to examine the level of DNA
fragmentation in hepatocyte nuclei in liver sections from Day 1 treated mice. Top. Representative photomicrographs are shown (magnification
200×). Bottom. The number of TUNEL-labeled nuclei was counted in 3 fields (magnification 200×) for each mouse and presented as the average.
The median number of TUNEL-positive nuclei in GC-C KO liver was 4 times that in WT liver (**P = 0.005; N = 6-7 mice per group).
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the regeneration process have not been explored.
GC-C has been localized to non-parenchymal cells
and hepatocytes [15,31] and although the cellular loca-
l i z a t i o no fG na n dU g ni sn o tk n o w nt h e i rd e t e c t i o n
and increased expression following CCl4 exposure (Fig-
ure 1) is consistent with a role for the GC-C receptor
signalling system during liver repair. In addition, both
Gn [32,33]and Ugn [34,35]are known to circulate in
the plasma. In response to CCl4 injury GC-C expres-
sion is also up-regulated in the mouse liver, as has pre-
viously been shown in rats [14]. In primary rat
hepatocyte cultures, the addition of glucocorticoids
and IL-6 [31], and both insulin and heregulin-b1[36],
have been shown to increase GC-C levels. Therefore,
we speculate that IL-6 [19], a key coordinator in the
response to liver injury, plays a role in mediating the
increased expression of GC-C that we and others have
observed.
While the level of hepatocyte proliferation after injury
is comparable to WT (Figure 8), GC-C deficiency
results in increased hepatocyte cell death (4 times the
level in WT liver) 1 day after CCl4 administration, as
well as an increased extent of necrotic areas at later
time points (Figures 4 &6). Our Caspase 3 studies (Fig-
ure 7) demonstrate that increased apoptosis also contri-
butes to the overall increased hepatocyte death in GC-C
null mice. This suggests that the mortality that occurs
within a few days of injury may be due to an imbalance
in the rates of hepatocyte loss and repopulation.
Increased levels of apoptosis have been demonstrated in
GC-C KO intestine in a non-lethal radiation model and
appear to be mediated by a cGMP-dependent mechan-
ism [5] while one study also demonstrated an increase
in crypt cell apoptosis in the GC-C KO intestine at
baseline compared to WT mice [6]. It is not known if
the protective mechanisms of GC-C signalling in the
intestine and liver are similar and further exploration is
warranted.
Figure 5 Histological analysis of WT and GC-C null mouse livers after CCl4 treatment. Paraffin-embedded sections from livers obtained 2
and 3 days after injection of 1 μl CCl4 per gram body weight in corn oil or corn oil only (vehicle) were stained with H&E. All CCl4 treated
sections show similar features of centrilobular necrosis as indicated by arrows, which appears to be more extensive in the GC-C KO (see Figure 6
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Figure 6 Increased area of necrotic damage in GC-C null mice.
H&E stained liver sections were evaluated by morphometric image
analysis to determine the extent of necrotic area. While the range
overlaps, GC-C KO mice exhibited more necrotic liver damage at
both 2 days (A) and 3 days (B) after CCl4 injection (*P = 0.04, N = 4-
8 mice per genotype). Data is presented as the mean percentage
necrosis in 3 fields (100×) per mouse. The bar is drawn at the
median value for all groups.
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Lack of GC-C expression in outbred mice versus inbred
C57BL6/J mice revealed a strain-specific protective role
f o rG C - Ci nt h el i v e rf o l l o w i n ga c u t eC C l 4 injury. In
contrast to WT littermates, GC-C null mice exhibited
near 100% lethality. Increased hepatocyte cell death due
to both necrosis and apoptosis occurred in the days
immediately following exposure in the GC-C KO mice
and likely contributed to mortality.
Acknowledgements
This work was supported by NIH grant R01 DK-47318 (M.B.C.) and by PHS
Grant P30 DK078392. We thank Jennifer A. Hawkins and Eleana Harmel-Laws
for technical expertise.
Author details
1Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati
Children’s Hospital Medical Center and the University of Cincinnati,
Cincinnati, OH, USA.
2Current address: Section of Comparative Pathology,
New England Primate Research Center, Harvard Medical School,
Southborough, MA, USA.
Authors’ contributions
EAM designed and performed the experiments, analyzed the data, and






































Days after CCL4 injection










































Figure 7 Increased post-CCl4 hepatocyte apoptosis in GC-C null livers . (A) Representative photomicrographs of cleaved Caspase 3 antibody
staining (brown color) in livers (counterstained with hematoxylin) from WT and GC-C KO mice at 2 days after CCl4 administration (200 ×
magnification). (B) Cleaved Caspase 3 stained cells were counted in 10 fields (200×) per mouse at the indicated times. Data is presented as the
mean number ± SEM, N = ≥ 4 mice per time point. *P = 0.04, GC-C KO vs. WT, Day 2. (C) Caspase 3 activity was measured using the
colorimetric substrate Ac-DEVD-pNA (N = ≥ 3mice per time point). Activity levels were normalized to the level seen in vehicle injected liver








































Figure 8 Timing and extent of hepatocyte proliferation post-
CCl4 is similar in both GC-C KO and WT. PCNA IHC was used to
examine hepatocyte entry into the cell cycle. Both PCNA-labeled
and unlabeled nuclei (counterstained with hematoxylin) were
counted in 3 fields (200×) and the percentage of PCNA-positive
nuclei was calculated (≥ 1100 total nuclei per mouse, N = ≥ 4 mice
per time point).
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